CN109381445A - 一种依托咪酯纳米制剂及其制备方法 - Google Patents
一种依托咪酯纳米制剂及其制备方法 Download PDFInfo
- Publication number
- CN109381445A CN109381445A CN201811424924.9A CN201811424924A CN109381445A CN 109381445 A CN109381445 A CN 109381445A CN 201811424924 A CN201811424924 A CN 201811424924A CN 109381445 A CN109381445 A CN 109381445A
- Authority
- CN
- China
- Prior art keywords
- etomidate
- nanometer formulation
- preparation
- nanometer
- polyvinyl alcohol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Anesthesiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
实施例1 | 实施例2 | 实施例3 | |
包封率(%) | 89.3 | 81.2 | 90.6 |
载药量(%) | 5.6 | 6.6 | 4.2 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811424924.9A CN109381445A (zh) | 2018-11-27 | 2018-11-27 | 一种依托咪酯纳米制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811424924.9A CN109381445A (zh) | 2018-11-27 | 2018-11-27 | 一种依托咪酯纳米制剂及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109381445A true CN109381445A (zh) | 2019-02-26 |
Family
ID=65429921
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811424924.9A Pending CN109381445A (zh) | 2018-11-27 | 2018-11-27 | 一种依托咪酯纳米制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109381445A (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3991072A (en) * | 1975-03-10 | 1976-11-09 | Janssen Pharmaceutica N.V. | Racemization of lower alkyl imidazole carboxylates |
CN106344521A (zh) * | 2016-09-30 | 2017-01-25 | 沈阳药科大学 | 一种高载药量可生物降解布比卡因微球的制备及其应用 |
CN107353418A (zh) * | 2016-05-09 | 2017-11-17 | 香港大学深圳医院 | 一种plga复合微球材料的制备方法 |
CN108451933A (zh) * | 2017-02-16 | 2018-08-28 | 人福普克药业(武汉)有限公司 | Nsaid缓释纳米颗粒及其制备方法 |
-
2018
- 2018-11-27 CN CN201811424924.9A patent/CN109381445A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3991072A (en) * | 1975-03-10 | 1976-11-09 | Janssen Pharmaceutica N.V. | Racemization of lower alkyl imidazole carboxylates |
CN107353418A (zh) * | 2016-05-09 | 2017-11-17 | 香港大学深圳医院 | 一种plga复合微球材料的制备方法 |
CN106344521A (zh) * | 2016-09-30 | 2017-01-25 | 沈阳药科大学 | 一种高载药量可生物降解布比卡因微球的制备及其应用 |
CN108451933A (zh) * | 2017-02-16 | 2018-08-28 | 人福普克药业(武汉)有限公司 | Nsaid缓释纳米颗粒及其制备方法 |
Non-Patent Citations (1)
Title |
---|
ZHANG ET AL.: "Long-acting hydrogel/microsphere composite sequentially releases dexmedetomidine and bupivacaine for prolonged synergistic analgesia", 《BIOMATERIALS》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102140989B1 (ko) | 개선된 점막 수송을 나타내는 제약 나노입자 | |
CN102302457B (zh) | 伊维菌素缓释微球的制备方法 | |
JP6067803B2 (ja) | ロチゴチン、その誘導体、又はロチゴチン若しくはその誘導体の薬学的に許容可能な塩の組成物 | |
CN107811967B (zh) | 抗寄生虫药物原位固化缓释注射剂及其制备方法 | |
CN1625391A (zh) | 包含环胞菌素的缓释药物组合物 | |
CN106727358A (zh) | 阿立哌唑及其衍生物的缓释组合物与该缓释组合物的制备方法 | |
CN104248628B (zh) | 一种利西拉来缓释微球及其制备方法 | |
CN101984958A (zh) | 纳米级阿苯达唑微粉及其制备方法 | |
CN107157957A (zh) | 黄体酮缓释微球及纳米粒、其制备方法和黄体酮缓释注射剂 | |
CN109381444A (zh) | 一种右美托咪定纳米制剂及其制备方法 | |
CN101721375B (zh) | 胰岛素缓释微米球组合物及其制备方法 | |
CN106727589A (zh) | 帕利哌酮及其衍生物的缓释组合物与该缓释组合物的制备方法 | |
Sanabria | Nanotechnological improvement of veterinary anthelmintics | |
CN109381445A (zh) | 一种依托咪酯纳米制剂及其制备方法 | |
CN102188391B (zh) | 制备粒细胞-巨噬细胞集落刺激因子微球的方法 | |
CN108210452B (zh) | 一种兽用喹赛多纳米混悬液及其制备方法 | |
CN101658493B (zh) | 阿奇霉素纳米结构脂质载体及其制备方法 | |
US9724307B2 (en) | Crosslinked nanoparticle composition | |
CN108815138B (zh) | 利培酮或其衍生物缓释微球、其制备方法及用途 | |
CN107982214A (zh) | 兽用恩诺沙星固体脂质纳米混悬液及其制备方法 | |
CN113546060A (zh) | 一种纳曲酮微球 | |
CN109453107A (zh) | 一种dna水凝胶介导的眼用药物输运系统及其制备方法和应用 | |
CN108635339B (zh) | 一种利培酮植入剂及其制备方法 | |
Zhang et al. | Preparation and characterization of lung-targeting cefquinome-loaded PLGA microspheres | |
Sapra et al. | Development of mucoadhesive microspheres for intranasal delivery of fluconazole as an alternative treatment of cryptococcal meningitis infection in patients with acquired immunodeficiency |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Luo Xu Inventor after: Gu Lu Inventor after: Ni Rongrong Inventor after: Sun Fengjun Inventor after: Zhang Dinglin Inventor after: Hu Jun Inventor before: Luo Xu Inventor before: Gu Lu Inventor before: Ni Rongrong Inventor before: Sun Fengjun Inventor before: Zhang Dinglin Inventor before: Hu Jun |
|
CB03 | Change of inventor or designer information | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190226 |
|
RJ01 | Rejection of invention patent application after publication |